Qiu Shi-jun, Zhang Xue-lin, Zhang Yan, Jiang Meng
Department of Diagnostic Imaging, Nangfang Hospital, Southern Medical University, Guangzhou 510515, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Mar;27(3):241-6.
To understand the metabolic patterns of NAA, Cr and Cho in radiation encephalopathy (RE) induced by radiotherapy for nasopharyngeal carcinoma detected by proton magnetic resonance spectroscopy (1H-MRS), and provide useful evidence for early diagnosis of this disease.
Chemical shift imaging 1H-MRS was performed for 10 healthy volunteers (control group) and 21 patients with pathologically confirmed nasopharyngeal carcinomas, who developed RE after radical radiotherapy as diagnosed on the basis of clinical symptoms and imaging findings. The contents of NAA, Cr and Cho in the pixels were observed, the metabolic maps generated, and NAA/Cr and NAA/Cho ratios calculated for all the subjects.
The concentrations of NAA, Cr and Cho were rarely observed in the necrosis and liquefaction foci in the patients, nor were any signals displayed on their metabolic maps. In the visible lesions, with the exception of the necrosis and liquefaction foci, the content of NAA increased slightly, whereas that of Cr or Cho decreased obviously or even became absent. An area around the lesion was identified where NAA content decreased but Cr or Cho increased. The signal in the metabolic maps appeared indistinguishable. The NAA/Cr and NAA/Cho ratios were less than 1. Farther away from the visible lesions, the NAA, Cr and Cho contents remained normal with NAA/Cr and NAA/Cho ratios of less than 1.
1H-MRS is capable of displaying the patterns of metabolite changes in RE induced by radiotherapy, and identifying larger area of abnormal metabolism in RE than the visible lesion in MRI, which suggests the possibility of earlier detection of RE with 1H-MRS.
通过质子磁共振波谱(1H-MRS)检测鼻咽癌放疗所致放射性脑病(RE)中N-乙酰天门冬氨酸(NAA)、肌酸(Cr)和胆碱(Cho)的代谢模式,为该病的早期诊断提供有用依据。
对10名健康志愿者(对照组)及21例经病理确诊为鼻咽癌且根治性放疗后出现RE的患者进行化学位移成像1H-MRS检查。RE的诊断基于临床症状和影像学表现。观察各像素点中NAA、Cr和Cho的含量,生成代谢图谱,并计算所有受试者的NAA/Cr和NAA/Cho比值。
患者坏死液化灶内很少观察到NAA、Cr和Cho的浓度,代谢图谱上也未显示任何信号。在可见病灶中,除坏死液化灶外,NAA含量略有增加,而Cr或Cho含量明显降低甚至消失。在病灶周围发现一个区域,NAA含量降低而Cr或Cho含量增加,代谢图谱上信号无明显差异。NAA/Cr和NAA/Cho比值均小于1。远离可见病灶处,NAA、Cr和Cho含量保持正常,NAA/Cr和NAA/Cho比值小于1。
1H-MRS能够显示放疗所致RE的代谢物变化模式,且能发现RE中比MRI可见病灶更大范围的代谢异常区域,提示1H-MRS有可能更早检测出RE。